Market capital is shifting from technology stocks toward healthcare and defensive sectors. Investors now question the valuations of AI infrastructure and the speed of returns on massive capital expenditures. This rotation suggests a cooling period for high-growth tech. Practitioners should expect tighter funding and increased pressure to prove immediate ROI on AI deployments.